A Study of Adebrelimab Combined With Famitinib and Chemotherapy in the Treatment of ES-SCLC.
Status:
NOT_YET_RECRUITING
Trial end date:
2027-04-15
Target enrollment:
Participant gender:
Summary
This is a single arm, multi-center, phase II trial to evaluate the efficacy, and safety of adebrelimab combined with famitinib and chemotherapy for the treatment of first-line extensive stage small cell lung cancer.
Phase:
PHASE2
Details
Lead Sponsor:
Harbin Medical University
Treatments:
Carboplatin Cisplatin Drug Therapy Etoposide famitinib